← FDA Drug Approvals (Drugs@FDA)

SILDENAFIL CITRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: UMEDICA · Approved 2020-08-25

Drug application

FDA Application #

ANDA209302

Application type

Abbreviated New Drug Application (Generic)

Brand name

SILDENAFIL CITRATE

Generic name

SILDENAFIL CITRATE

Active ingredients

SILDENAFIL CITRATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

UMEDICA

Manufacturer

Umedica Laboratories USA Inc.

First approval

2020-08-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown